DongKoo Bio & Pharma Co., Ltd.

KOSDAQ:A006620 Stock Report

Market Cap: ₩136.8b

DongKoo Bio & Pharma Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Cho Yong-Jun

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership30.6%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Aug 23
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

Jul 25
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

CEO

Cho Yong-Jun

no data

Tenure

Mr. Cho Yong-Jun serves as the President at DongKoo Bio & Pharma Co., Ltd. and serves as its Chief Executive Officer.